INIS
risks
100%
lupus
75%
cardiovascular diseases
41%
patients
41%
populations
33%
comparative evaluations
25%
reviews
25%
modifications
16%
management
16%
control
16%
atherosclerosis
16%
mortality
8%
women
8%
guidelines
8%
morbidity
8%
recommendations
8%
causality
8%
Medicine and Dentistry
Systemic Lupus Erythematosus
75%
Cardiovascular Disease
41%
Inpatient
33%
Population
16%
Risk Factor Modification
16%
Therapeutic Procedure
16%
Randomized Controlled Trial
16%
Morbidity
8%
Prevalence
8%
Causality
8%
Cardiovascular Risk
8%
Cardiovascular Disease Risk Factor
8%
Framingham Risk Score
8%
Mortality
8%
Population Dynamics
8%
Patient
8%
Young Woman
8%
Immunology and Microbiology
Systemic Lupus Erythematosus
75%
Population
16%
Atherosclerosis
16%
Morbidity
8%
Prevalence
8%
Population Dynamics
8%
Mortality
8%
Pharmacology, Toxicology and Pharmaceutical Science
Systemic Lupus Erythematosus
75%
Atherosclerosis
16%
Causality
8%
Cardiovascular Risk
8%
Morbidity
8%
Prevalence
8%
Framingham Risk Score
8%
Mortality
8%
Psychology
Systemic Lupus Erythematosus
75%
Cardiovascular Disease
41%
Treatment
16%